Silver(I) and gold(I)–N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligand were examined for cytotoxicity in normal and tumor cells. The silver(I) complex exhibits greater cytotoxicity in tumor cells compared with normal cells. Notably, in cell extracts, this complex determines a more pronounced inhibition of thioredoxin reductase (TrxR), but it is ineffective towards glutathione reductase (GR). Both gold and silver complexes lead to oxidation of the thioredoxin system, the silver(I) derivative being particularly effective. In addition, the dimerization of peroxiredoxin 3 (Prx3) was also observed, demonstrating the ability of these compounds to reach the mitochondrial target. The fluorescence microscopy visualizat...
N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and ...
International audienceFourteen silver(I) complexes bearing N-heterocyclic carbene (NHC) ligands were...
Among the non-platinum antitumor agents, gold complexes have received increased attention owing to t...
Silver(I) and gold(I) N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligan...
Silver(I) and gold(I)-N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligan...
Silver(I) and gold(I)-N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligan...
The silver(I) N-heterocyclic carbene (NHC) complex bis(1-(anthracen-9-ylmethyl)-3-ethylimidazol-2-yl...
A silver(I) and a gold(I) complex of the fluorescent N-heterocyclic carbenic (NHC) ligand 1-(9-anthr...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of th...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of th...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of th...
N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and ...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of t...
N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and ...
N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and ...
International audienceFourteen silver(I) complexes bearing N-heterocyclic carbene (NHC) ligands were...
Among the non-platinum antitumor agents, gold complexes have received increased attention owing to t...
Silver(I) and gold(I) N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligan...
Silver(I) and gold(I)-N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligan...
Silver(I) and gold(I)-N-heterocyclic carbene (NHC) complexes bearing a fluorescent anthracenyl ligan...
The silver(I) N-heterocyclic carbene (NHC) complex bis(1-(anthracen-9-ylmethyl)-3-ethylimidazol-2-yl...
A silver(I) and a gold(I) complex of the fluorescent N-heterocyclic carbenic (NHC) ligand 1-(9-anthr...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of th...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of th...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of th...
N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and ...
Gold(I) complexes with 1,3-substituted imidazole-2-ylidene and benzimidazole-2-ylidene ligands of t...
N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and ...
N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and ...
International audienceFourteen silver(I) complexes bearing N-heterocyclic carbene (NHC) ligands were...
Among the non-platinum antitumor agents, gold complexes have received increased attention owing to t...